Literature DB >> 7206163

Mortality in an insured population with atrial fibrillation.

J Gajewski, R B Singer.   

Abstract

In a cooperative study of 3,099 life insurance applicants with atrial fibrillation (AF), 71 deaths over an average duration of 3.3 years were observed and compared with deaths expected and derived from standard insurance mortality tables. A normal mortality was observed in cases of paroxysmal AF with no other identified cardiovascular impairment. Paroxysmal AF with associated mitral stenosis or coronary disease was found to have a significantly increased mortality. Chronic AF with or without other impairments entails a much higher risk than paroxysmal AF, those cases associated with mitral stenosis showing very high excess mortality.

Entities:  

Mesh:

Year:  1981        PMID: 7206163

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  16 in total

Review 1.  Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.

Authors:  S Saskena; M J Domanski; E J Benjamin; A J Camm; M D Ezekowitz; B J Gersh; J Jalife; G V Naccarelli; R E Vlietstra; D G Wyse
Journal:  J Interv Card Electrophysiol       Date:  2001-09       Impact factor: 1.900

Review 2.  Chronic and paroxysmal atrial fibrillation: course, prognosis, and stroke risk.

Authors:  T E Cuddy
Journal:  J Thromb Thrombolysis       Date:  1999-01       Impact factor: 2.300

Review 3.  Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management.

Authors:  I Savelieva; A J Camm
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

Review 4.  Non-rheumatic atrial fibrillation: warfarin or aspirin for all?

Authors:  J Nolan; P Bloomfield
Journal:  Br Heart J       Date:  1992-12

Review 5.  Pacing in prevention of atrial fibrillation: the PIPAF studies.

Authors:  F Anselme; N Saoudi; A Cribier
Journal:  J Interv Card Electrophysiol       Date:  2000-01       Impact factor: 1.900

Review 6.  Genetics of atrial fibrillation.

Authors:  Steven A Lubitz; B Alexander Yi; Patrick T Ellinor
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

7.  Atrial fibrillation and embolism.

Authors:  J A Milliken
Journal:  Can Med Assoc J       Date:  1983-06-15       Impact factor: 8.262

8.  Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke.

Authors:  Jonathan P Piccini; Bradley G Hammill; Moritz F Sinner; Adrian F Hernandez; Allan J Walkey; Emelia J Benjamin; Lesley H Curtis; Susan R Heckbert
Journal:  Eur Heart J       Date:  2013-11-25       Impact factor: 29.983

9.  Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years.

Authors:  Joon Hoon Jeong
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

Review 10.  Physicians' attitudes and the use of oral anticoagulants: surveying the present and envisioning future.

Authors:  Meghan York; Ashish Agarwal; Michael Ezekowitz
Journal:  J Thromb Thrombolysis       Date:  2003 Aug-Oct       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.